AEMD MEXC RealStocks
Own real AEMD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 16:04:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
AETHLON MEDICAL INC. (AEMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.32, with a market capitalization of $3.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.41 to $25.66. This page covers its latest market performance, valuation, price trends and company information.
$3.97M | |
$5.64 | |
$5.64 | |
$5.10 | |
$5.58 | |
9.67K | |
2.60M | |
-- | |
$25.66 | |
$1.41 | |
-- | |
-- |
AETHLON MEDICAL INC. (AEMD) is currently trading at $5.32 as of 2026-11-13 15:54:00, down 6.27% ($0.35) from the previous close of $5.58
During today's regular trading session, AEMD has traded between $5.10 and $5.64, with a trading volume of 9.67K shares. The current price is near the middle of today's range.
Over the past seven days, AETHLON MEDICAL INC. (AEMD) moved from $5.31 to $5.32, representing a gain of 0.19% ($0.01).
The stock traded between $5.10 and $5.81 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 13.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 16.1%
AEMD is currently trading at $5.32, placing it 16.1% of the way from its 52-week low of $1.41 to its 52-week high of $25.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AETHLON MEDICAL INC. (AEMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AEMD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AEMD shares and USD.
AEMD Shares to USD
1.00 AEMD shares = 5.32 USD
Calculations are estimates based on the latest available price and are for reference only.